(Q33709767)

28 July 2017

1 reference

title

Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma? (English)

1 reference

28 July 2017

1 reference

1 reference

Simons FE

1

1 reference

28 July 2017

1 July 1999

1 reference

Clinical & Experimental Allergy

28 July 2017

1 reference

28 July 2017

29 Suppl 3

1 reference

28 July 2017

98-104

1 reference

The pharmacology and use of H1-receptor-antagonist drugs

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.0290S3098.X

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.0290S3098.X

A double-blind, placebo controlled study of the effect of the specific histamine H1-receptor antagonist, terfenadine, in chronic severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.0290S3098.X

A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.0290S3098.X

Terfenadine, a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.0290S3098.X

Does ketotifen have a steroid-sparing effect in childhood asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.0290S3098.X

The use of the nose to study the inflammatory response of the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.1999.0290S3098.X

10.1046/J.1365-2222.1999.0290S3098.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10444221